Hepatitis C Drug Market By Drug Class (Direct-Acting Antivirals (DAAs) {NS3/4A Protease Inhibitors, NS5A Inhibitors, NS5B Polymerase Inhibitors}, Combination Therapy {Sofosbuvir-Ledipasvir, Sofosbuvir-Velpatasvir, Sofosbuvir-Velpatasvir-Voxilaprevir, Glecaprevir-Pibrentasvir}, Interferons {Pegylated Interferon Alpha}, Other), By Route of Administration (Oral, Injectable, Other), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics), By End-User (Hospitals, Specialty Clinics, Home Care Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Class

• Direct-Acting Antivirals (DAAs)
  • NS3/4A Protease Inhibitors
  • NS5A Inhibitors
  • NS5B Polymerase Inhibitors
• Combination Therapy
  • Sofosbuvir-Ledipasvir
  • Sofosbuvir-Velpatasvir
  • Sofosbuvir-Velpatasvir-Voxilaprevir
  • Glecaprevir-Pibrentasvir
• Interferons
  • Pegylated Interferon Alpha
• Other

By Route of Administration

• Oral
• Injectable
• Other

By Disease Type

·Acute Hepatitis C

·Chronic Hepatitis C

 By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Specialty Clinics

By End-User

• Hospitals
• Specialty Clinics
• Home Care Settings

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Gilead Sciences
• AbbVie Inc.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Roche Holding AG
• GlaxoSmithKline plc
• Novartis AG
• Pfizer Inc.
• Regulus Therapeutics Inc.
• Ascletis Pharma Inc.
• Zydus Cadila
• Cipla Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Hetero Drugs Ltd.